Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access

Ian Hirsch, Daniel A. Goldstein, Ian F. Tannock, Marcus O. Butler, Duncan C. Gilbert*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2236-2237
Number of pages2
JournalNature Medicine
Issue number11
StatePublished - Nov 2022

Cite this